SIRT1 and myeloid sarcoma: Numerous studies of multiple sclerosis (MS) showed that SIRT1 was upregulated in acute and chronic brain lesions, and reduced in the peripheral blood during MS exacerbations, and the overexpression of SIRT1 was neuroprotective6.